The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports

European Journal of Clinical Pharmacology
Hieronymus J DerijksAntoine C G Egberts

Abstract

Depression is common in patients with diabetes, and the use of antidepressants may impair glycaemic control. We assessed the association between antidepressant use and hyper- and hypoglycaemia. Based on spontaneous reports listed in the World Health Organization (WHO) Adverse Drug Reaction Database, a case-control study was conducted. The study base consisted of all adverse drug reactions (ADRs) ascribed to antidepressants, antipsychotics and benzodiazepines between 1969 and 2005. Cases were defined as reported ADRs classified as hyper- or hypoglycaemia and separated in different study populations. All other reports were considered as controls. Exposure to antidepressants was the primary determinant investigated. Benzodiazepines and antipsychotics were chosen as reference groups. Potential confounding factors, namely, age, gender, use of antidiabetic medication, use of hyper- or hypoglycaemia-inducing comedication and reporting year, were determined on the index date. Multivariate logistic regression was used to evaluate the strength of the association, which was expressed as reporting odds ratios (RORs) with 95% confidence intervals (95% CI). Overall, the use of antidepressants was associated with hyperglycaemia [ROR 1.52 (95%...Continue Reading

References

Apr 1, 1989·Diabetes Care·R G PestellJ D Best
Mar 1, 1989·American Journal of Public Health·S Greenland
Apr 1, 1995·The Journal of Clinical Psychiatry·P J GoodnickV M Buki
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Apr 1, 1993·Annals of Internal Medicine·M K PanditA N Peiris
Mar 1, 1996·Diabetes Care·F E Van der DoesR J Heine
May 26, 2001·Diabetes Care·R J AndersonP J Lustman
Aug 4, 2001·Psychosomatic Medicine·M A Van TilburgR S Surwit
Nov 3, 2001·JAMA : the Journal of the American Medical Association·B Luna, M N Feinglos
Aug 16, 2003·Journal of Clinical Psychopharmacology·Frank GianfrancescoHenry A Nasrallah
Nov 19, 2003·Journal of Clinical Psychopharmacology·Mahomed Y H MoosaBarry I Joffe
Nov 12, 2005·Journal of Clinical Psychopharmacology·Hieronymus J DerijksAntoine C G Egberts
Dec 24, 2005·Expert Opinion on Drug Safety·Roger S McIntyreSidney H Kennedy
May 3, 2006·The Journal of Clinical Psychiatry·Markus LaimerChristoph F Ebenbichler

❮ Previous
Next ❯

Citations

Oct 17, 2012·Der Nervenarzt·M Deuschle, U Schweiger
Apr 14, 2011·International Journal of Clinical Pharmacy·Star Khoza, Jamie C Barner
Jan 18, 2012·International Journal of Clinical Pharmacy·Star KhozaJames P Wilson
Nov 29, 2012·Current Opinion in Psychiatry·Michael Deuschle
Jun 24, 2014·Diabetes Research and Clinical Practice·Rituparna BhattacharyaUsha Sambamoorthi
Mar 1, 2012·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Marie-Catherine FrancinoDominique Perrotin
Aug 23, 2011·La Revue de médecine interne·S TaugourdeauM-J Jean-Pastor
Sep 27, 2015·Psychopharmacology·Virginio SalviGiuseppe Maina
Feb 4, 2009·Psychoneuroendocrinology·Sofie WestlingLil Träskman-Bendz
Sep 16, 2015·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Neila FathallahChaker Ben Salem
Nov 26, 2015·Indian Journal of Pharmacology·Ranjita Santra DhaliPatralekha Ray Chaudhuri
Jun 15, 2014·Endocrine·Vincenzo FioreVincenzo Triggiani
Nov 20, 2014·European Journal of Clinical Pharmacology·Miran BrvarLucija Peterlin Mašič
Sep 7, 2016·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Virginio SalviFrancesco Barone-Adesi
Oct 16, 2012·Journal of Diabetes Science and Technology·Ajay K ParsaikYogish C Kudva
Aug 2, 2013·Korean journal of family medicine·Jae Moon YoonSang Min Park
Jun 29, 2018·British Journal of Clinical Pharmacology·Spyridon Siafis, Georgios Papazisis
Jul 14, 2009·Journal of Clinical Psychopharmacology·Hieronymus J DerijksAntoine C G Egberts
Oct 15, 2010·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Chaker Ben SalemKamel Bouraoui
Nov 29, 2011·European Journal of Clinical Pharmacology·S KhozaJ P Wilson
Jan 7, 2020·International Anesthesiology Clinics·C James WatsonMichael Ganetsky
Jul 4, 2012·Human & Experimental Toxicology·R KhanamD Vohora
Jul 9, 2020·Journal of Clinical Psychopharmacology·Hsin-Ya KuoChe-Sheng Chu
Jul 11, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Sue M PenckoferPatrick Lustman
Feb 6, 2017·Journal of Medical Case Reports·Fawzi A Bachet IbrahimA Bashier
Jul 17, 2019·The Journal of Pharmacology and Experimental Therapeutics·Weibin ZhaJoanne Wang
Apr 3, 2020·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Junichi MukaiRie Kubota
Jul 15, 2021·The Journal of Clinical Endocrinology and Metabolism·Chi-Shin WuShi-Heng Wang
Sep 12, 2021·Journal of Clinical Psychopharmacology·Nirmal SinghRishab Gupta

❮ Previous
Next ❯

Software Mentioned

SPSS
Vigibase

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here